Tuesday, May 7, 2024

🌎 Omnicom Group Upgraded, Integra LifeSciences Downgraded, Advanced Micro Devices Upgraded and more...

Ratings changes for PLAYSTUDIOS, NMI, Rocket Pharmaceuticals, EverQuote, Celldex Therapeutics, Territorial Bancorp, SI-BONE and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Unsubscribe.
MarketBeat Daily Ratings
May 7th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 

Today's Top Stories
Pinterest Prospers From AI Boosting Shop-Ability and Relevance
TikTok sues the US over attempts to force its Chinese parent to sell the social media platform, citing First Amendment
Your $200 MarketBeat account credit is about to expire (MarketBeat Internal)
AbbVie Tracking for New Highs in 2024
Apple's biggest announcements from its iPad event: brighter screen, faster processors and new sizes
3 Automotive Parts Makers Growing at Double-Digit Rates
New York governor regrets saying Black kids in the Bronx don't know what a computer is
Elon to Transform U.S. Economy? (Porter & Company)
Freshpet Surges 10%: Fresh Highs to Come for This Pet Stock
Deadline for businesses to apply for their share of massive credit card company settlement looms
Hims & Hers Health Stock Could Become a Wealth Compounder
Luis Miranda Jr. reflects on giving, the arts and his son Lin-Manuel in the new memoir 'Relentless'
Amazon Stands Tall: New Highs Are in Sight
Quick Links

Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Advanced Micro Devices (NASDAQ:AMD) was upgraded by analysts at DZ Bank AG from a "hold" rating to a "buy" rating. They now have a $190.00 price target on the stock. This represents a 21.7% upside from the current price of $156.16.
  • Cognex (NASDAQ:CGNX) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.The current price is $46.10.
  • Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $12.00 price target on the stock, up previously from $6.00. This represents a 159.2% upside from the current price of $4.63.
  • GAP (NYSE:GPS) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $28.00 price target on the stock, up previously from $21.00. This represents a 24.0% upside from the current price of $22.58.
  • Cloudflare (NYSE:NET) was upgraded by analysts at DZ Bank AG from a "hold" rating to a "buy" rating. They now have a $95.00 price target on the stock. This represents a 27.6% upside from the current price of $74.43.
  • Omnicom Group (NYSE:OMC) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $110.00 price target on the stock, up previously from $100.00. This represents a 16.9% upside from the current price of $94.08.
  • Koninklijke Philips (NYSE:PHG) was upgraded by analysts at BNP Paribas from an "underperform" rating to a "neutral" rating.The current price is $26.72.
  • Insulet (NASDAQ:PODD) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $200.00 price target on the stock. This represents a 9.4% upside from the current price of $182.77.
  • Sunstone Hotel Investors (NYSE:SHO) was upgraded by analysts at Compass Point from a "sell" rating to a "neutral" rating. They now have a $12.00 price target on the stock, up previously from $10.00. This represents a 14.1% upside from the current price of $10.52.
  • Territorial Bancorp (NASDAQ:TBNK) was upgraded by analysts at Piper Sandler from an "underweight" rating to a "neutral" rating. They now have a $8.50 price target on the stock, up previously from $8.00. This represents a 3.9% upside from the current price of $8.18.
  • Target (NYSE:TGT) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $180.00 price target on the stock. This represents a 12.2% upside from the current price of $160.47.
  • Ubisoft Entertainment (OTCMKTS:UBSFY) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating.The current price is $4.62.
  • Vale (NYSE:VALE) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $15.00 price target on the stock, up previously from $13.00. This represents a 17.2% upside from the current price of $12.80.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • CVS Health (NYSE:CVS) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating. They now have a $59.00 price target on the stock, down previously from $99.00. This represents a 4.6% upside from the current price of $56.38.
  • Integra LifeSciences (NASDAQ:IART) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $25.00 price target on the stock, down previously from $45.00. This represents a 0.7% upside from the current price of $24.83.
  • Integra LifeSciences (NASDAQ:IART) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $24.83.
  • Lyra Therapeutics (NASDAQ:LYRA) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating.The current price is $0.42.
  • Lyra Therapeutics (NASDAQ:LYRA) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $0.50 price target on the stock, down previously from $10.00. This represents a 19.0% upside from the current price of $0.42.
  • Lyra Therapeutics (NASDAQ:LYRA) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $2.00 price target on the stock, down previously from $12.00. This represents a 376.2% upside from the current price of $0.42.
  • Teradata (NYSE:TDC) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $39.00 price target on the stock, down previously from $48.00. This represents a 18.1% upside from the current price of $33.01.
  • Vestis (NYSE:VSTS) was downgraded by analysts at Redburn Atlantic from a "buy" rating to a "neutral" rating. They now have a $13.40 price target on the stock. This represents a 30.5% upside from the current price of $10.27.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Ares Management (NYSE:ARES) is now covered by analysts at TD Cowen. They set a "buy" rating and a $154.00 price target on the stock. This represents a 10.9% upside from the current price of $138.90.
  • Corning (NYSE:GLW) is now covered by analysts at Mizuho. They set a "neutral" rating and a $36.00 price target on the stock. This represents a 7.3% upside from the current price of $33.56.
  • Joint Stock Company Kaspi.kz (NASDAQ:KSPI) is now covered by analysts at New Street Research. They set a "buy" rating and a $175.00 price target on the stock. This represents a 46.5% upside from the current price of $119.48.
  • LanzaTech Global (NASDAQ:LNZA) is now covered by analysts at TD Cowen. They set a "hold" rating and a $3.00 price target on the stock. This represents a 10.7% upside from the current price of $2.71.
  • Metagenomi (NASDAQ:MGX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock. This represents a 57.0% upside from the current price of $6.37.
  • Summit Therapeutics (NASDAQ:SMMT) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $7.00 price target on the stock. This represents a 41.7% upside from the current price of $4.94.
  • UL Solutions (NYSE:ULS) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $42.00 price target on the stock. This represents a 18.3% upside from the current price of $35.51.
  • UL Solutions (NYSE:ULS) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $40.00 price target on the stock. This represents a 12.6% upside from the current price of $35.51.
  • UL Solutions (NYSE:ULS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $41.00 price target on the stock. This represents a 15.5% upside from the current price of $35.51.
  • UL Solutions (NYSE:ULS) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $40.00 price target on the stock. This represents a 12.6% upside from the current price of $35.51.
  • UL Solutions (NYSE:ULS) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $39.00 price target on the stock. This represents a 9.8% upside from the current price of $35.51.
  • UL Solutions (NYSE:ULS) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $40.00 price target on the stock. This represents a 12.6% upside from the current price of $35.51.
  • UL Solutions (NYSE:ULS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $42.00 price target on the stock. This represents a 18.3% upside from the current price of $35.51.
  • UL Solutions (NYSE:ULS) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $38.00 price target on the stock. This represents a 7.0% upside from the current price of $35.51.
  • UL Solutions (NYSE:ULS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $39.00 price target on the stock. This represents a 9.8% upside from the current price of $35.51.
  • UL Solutions (NYSE:ULS) is now covered by analysts at Raymond James. They set an "outperform" rating and a $42.00 price target on the stock. This represents a 18.3% upside from the current price of $35.51.
  • UL Solutions (NYSE:ULS) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $35.51.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: If you have $2,500 bucks… Take a look at this. (Click to Opt-in)
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Why the "January Effect" could signal a market reversal!

Watch out for this as we wrap up the year! ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏...